Miss Hang Su
1 - 2 out of 2Page size: 50
- Article › Research › Peer-reviewed
-
Cost-effectiveness of edaravone dexborneol versus edaravone for the treatment of acute ischemic stroke in China: Based on the TASTE study
Shi, F., He, Z., Wang, L., Su, H. & Han, S., 18 Oct 2022, In: Frontiers in Pharmacology. 13Research output: Contribution to journal › Article › peer-review
-
Economic evaluation of Tislelizumab Versus Chemotherapy as Second Line Treatment for Advanced or Metastatic Esophageal Squamous Cell Carcinoma in China
Shi, F., He, Z., Su, H., Wang, L. & Han, S., 16 Nov 2022, In: Frontiers in Pharmacology. 13Research output: Contribution to journal › Article › peer-review